ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

174
Analysis
Health Care • South Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
bullish•Snowflake
•18 Dec 2020 00:34

Review of Our IPO Research in 2020 & Change in Our IPO Research Process for 2021

In this report, we review our IPO investment research in 2020, including the performance of our calls and how we plan to change our process of...

Logo
973 Views
Share
bullish•Krafton
•14 Dec 2020 09:14

2021 Major IPOs Pipeline in Korea

This is our 6th "Annual Edition of the Major Korean IPOs Pipeline Preview" already at Smartkarma! In this report, we have identified 50 companies...

Logo
762 Views
Share
•26 Oct 2020 09:29

KOSPI200 Index Rebalance Preview: Review Period Nearly Complete, Nine (Or Ten) Possible Changes

The KOSPI200 index review will be announced in the next 4 weeks. We see 9 inclusions/ exclusions and significant volume to sell on the deletions....

Logo
606 Views
Share
bullish•HYBE
•16 Sep 2020 10:53
Logo
539 Views
Share
bullish•Kakao Games
•10 Sep 2020 06:08
Logo
523 Views
Share
x